Skip to main content
CORCEPT THERAPEUTICS INC logo

CORCEPT THERAPEUTICS INC — Investor Relations & Filings

Ticker · CORT ISIN · US2183521028 LEI · 529900EO9LUTFMZ7FF90 US Manufacturing
Filings indexed 1,284 across all filing types
Latest filing 2026-04-17 Proxy Solicitation & In…
Country US United States of America
Listing US CORT

About CORCEPT THERAPEUTICS INC

https://www.corcept.com/

Corcept Therapeutics Inc. is a commercial-stage pharmaceutical company engaged in the discovery, development, and commercialization of medications. The company focuses on cortisol modulation, developing molecules that regulate cortisol activity at the glucocorticoid receptor (GR). Its primary mission is to create novel treatments for severe disorders. Corcept's research and development efforts span multiple therapeutic areas, including endocrinology, oncology, metabolism, and neurology, aiming to address serious diseases impacted by cortisol.

Recent filings

Filing Released Lang Actions
DEF 14A - CORCEPT THERAPEUTICS INC (0001088856) (Filer)
Proxy Solicitation & Information Statement
2026-04-17 English
4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
Director's Dealing
2026-03-27 English
SCHEDULE 13G/A - CORCEPT THERAPEUTICS INC (0001088856) (Subject)
Major Shareholding Notification
2026-03-26 English
144 - CORCEPT THERAPEUTICS INC (0001088856) (Subject)
Regulatory Filings
2026-03-25 English
8-K - CORCEPT THERAPEUTICS INC (0001088856) (Filer)
Regulatory Filings
2026-03-25 English
4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
Director's Dealing
2026-03-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.